Tangential flow filtration (TFF) is one of the key technologies used to purify and concentrate target proteins in downstream processing of protein-based biopharmaceuticals. This technology can gently and efficiently process large amounts of protein solutions while minimizing sample loss and maintaining the integrity of sensitive molecules. CD Formulation integrates cutting-edge TFF technology into our protein characterization technology platform to provide reliable analytical support for the downstream process development of your protein/peptide drugs.
TFF, also known as cross-flow filtration, is an important technology in bioprocessing and purification that can be used to separate, concentrate, and purify biomolecules such as proteins, enzymes, viruses, and cells. This technology is a method that uses ultrafiltration membranes to quickly and efficiently separate and purify biomolecules. Unlike traditional filtration methods that use filters to directly capture particles or solutes, TFF uses a flow path design that allows the liquid flow to flow tangentially to the surface of the filter membrane instead of passing through the membrane vertically, which would clog the filter media. This method is favored for its continuous filtration and reproducible performance.
Fig. 1 A schematic illustration of a tangential flow filtration system. (Visan KS, et al., 2022)
In the downstream processing of protein biopharmaceuticals, TFF technology is mainly used for the concentration and diafiltration of target protein or peptide molecules.
Thanks to decades of experience supporting protein/peptide biopharmaceutical development and manufacturing using TFF technology, our team of highly qualified experts offers a range of TFF-related services to accelerate the implementation and success of your project.
Our experienced team of experts has completed hundreds of TFF separation and purification projects for protein and peptide, supporting all stages of your protein/peptide drug development and manufacturing - from early studies to downstream process monitoring and GMP batch release testing.
Utilizing cutting-edge TFF technology, we support the following protein/peptide development and characterization plans, including but not limited to:
The membrane structure designed for the TFF system is very different from the membrane structure used in direct flow filtration. Throughout the TFF system design process, our team of process development experts focuses on the following factors to solve any possible challenges you may have.
This can be defined by molecular weight or size. Generally, when separating by molecular weight, we will choose a membrane that is 1/6 to 1/3 smaller than the target molecule, while when separating by molecular size, we will choose a membrane with a pore size smaller than the target molecule.
Our scientists will customize the design according to your needs. For components that need to be retained, concentration is the best, while for components that need to be removed, dialysis, desalting, and buffer exchange are our important strategies.
Recovery is related to molecular weight cutoff (MWCO). We will screen the best filtration membrane based on your recovery needs. If a lower recovery rate is acceptable, a membrane with a MWCO of 1/3 of the target molecule will help speed up the recovery process. If higher recovery is required, membranes with MWCO as low as 1/6 are your best choice.
We provide you with professional protein/peptide downstream processing services using the following two TFF analysis technologies. The main difference between these two TFFs is the number of passes of the feed solution.
In a single-pass TFF process, the liquid passes through the membrane element in a tangential flow. The required protein concentration or buffer exchange occurs in a single pass, which can be achieved by adjusting the TMP or increasing the residence time in the filter. This approach usually improves separation efficiency and reduces membrane fouling.
In traditional TFF, the feed solution passes through the filter multiple times, and the buffer composition in the feed solution is changed to concentrate the protein solution. This is because the filters used in traditional TFF usually allow higher feed flux, resulting in increased sweep rate and shortened residence time, thus requiring multiple passes.
Fig. 2 Schematic of a) traditional TFF and b) SP-TFF setup. (S Malladi, et al., 2023)
Published Data
Technology: Single-Pass Tangential Flow Filtration (SP-TFF)
Journal: Journal of Membrane Science.
IF: 8.34
Published: 2023
Results:
The authors describe a step-by-step approach for implementing robust SP-TFF operations in either batch or continuous formats. The SP-UF/SP-DF operations were validated using an integrated experimental, modeling, and simulation approach. Validation was demonstrated by operating a single-pass tangential flow filtration (SP-TFF) system in an integrated and continuous manner for commercial scale. The results show that this step-by-step approach is applicable to any type of biomanufacturing process, e.g., batch or cyclic batch.
Fig. 3 Schematic overview of the integrated and continuous SP-UF1, SP-DF, and SP-UF2 operations. (S Malladi, et al., 2023)
CD Formulation aims to provide a powerful analytical tool for the separation, purification, and characterization of proteins and peptides. Please feel free to contact us if you are interested in our services. Learn how our TFF technology can support the smooth implementation of your protein/peptide biopharmaceutical program.
References